• Stroke treatment device now approved for general use


    Kalamazoo, Michigan: Stryker Corporation has announced that two of its intravenous clot-retrieval devices have been approved for general use on stroke patients by the US Food and Drug Administration (FDA). The Trevo ProVue retriever is a catheter device which is inserted intravenously and guided by fluoroscopic imaging; using a grappling tool, it can grip and remove a blood clot, greatly reducing the chances of the patient suffering paralysis, speech difficulties and other effects associated with a stroke. Previously, the device was only approved for patients who could not be treated with the common clot-dissolving drug t-PA. “This is the first time FDA has allowed the use of these devices alongside [the clot-dissolving drug]t-PA, which has the potential to help further reduce the devastating disabilities associated with strokes compared to the use of t-PA alone,” Carlos Peña, director of the division of neurological and physical medicine devices at the FDA’s Center for Devices and Radiological Health, said in a statement. According to the US National Institutes for Health, stroke is the fifth-leading cause of death in the US, and the second-leading cause of death in the Philippines.


    Please follow our commenting guidelines.

    Comments are closed.